Feline vaccines against avian influenza
AssigneeMerial Limited
InventorsHervé Poulet, Jean Christophe Audonnet, Michel Bublot, Jiansheng Yao
Life of this patent
Estimating the term…
Abstract
The present invention encompasses influenza vaccines, in particular avian influenza vaccines. The vaccine may be a recombinant poxvirus vaccine or an inactivated vaccine. The invention also encompasses recombinant poxvirus vectors encoding and expressing avian influenza antigens, epitopes or immunogens which can be used to protect animals, in particular felids, against avian influenza.
Claims13
An immunological composition comprising an avipox expression vector, wherein said expression vector comprises a polynucleotide encoding an influenza antigen comprising a polypeptide having the amino acid sequence of, SEQ ID NO:17, and wherein the composition comprises in an effective amount of the avipoxvirus vector expressing the influenza virus antigen set forth in SEQ ID NO:
- 7 for inducing an immune response against H5 avian influenza virus infection.
Dependencies are inferred from the claim text.